AN UNBIASED VIEW OF MBL77

gene in individuals relapsing soon after treatment With all the BCL2 antagonist venetoclax. 66 Resistance to these agents has been linked to these mutations in close to 70% of circumstances, Despite the fact that they are frequently subclonal as well as their particular purpose producing resistance needs to be established.Over the past many years,